Dr. Mudassar Amin

Therapy Areas: Acne, Atopic Dermatitis, Hyperpigmentation

• Product Portfolio: Benzac range, Cetaphil BHR, Cetaphil Pro Urea & Cetaphil Velvet Range.

• Build strong scientific partnerships with dermatologists and KOLs through advisory boards, CMEs, and clinical discussions.

• Provide pan-India medical education via CMEs, scientific updates, and evidence-based engagement.

• Training Leadership: Conduct scientific training for Healthy Skin Advisors, Nurses, Pharmacists & Sales Teams on skincare science, CTMP regimen, and patient-centric communication.

• Drive medical support for brand strategy, new product launches, and real-world evidence initiatives.

• Collaborate with cross-functional teams (Marketing, Regulatory, Commercial) to align medical strategy with business priorities.

• - Spearheaded medical strategies for key molecules in Metabolic therapy area, including Thyroxine, Liothyronine, and Dienogest, across West & East India, engaging with Endocrinologists, OBGYNs, MD Medicine and Cardiologists.
• - Moderated CMEs and supported scientific request to the KOLs for National level conferences, representing Abbott Pharmaceuticals.
• - Facilitated collaboration with KOLs to drive insights on product positioning and market trends.

• - Led strategic discussions with KOLs across multiple specialties (Endocrinology, Cardiology, MD Medicine, Nephrology) for the promotion of anti-diabetic drugs like Remogliflozin (SGLT2 inhibitors) and Sitagliptin (DPP4 inhibitors).
• - Coordinated and hosted multiple CMEs, contributing to the education of healthcare professionals on cutting-edge treatment options in Cardio-Diabetes care.
• - Provided clinical insights that contributed to the development of medical education programs.

• - Conducted patient assessments in COVID ICU and Wards during Pandemic.
• - Led daily CTVS ICU & ward rounds and managed patient care under the guidance of consultants.

• - Served as the primary hospital physician for inpatient care, conducting detailed assessments and managing treatment plans.
• - Conducted patient assessments in COVID ICU and Wards during Pandemic.